Latvij\u0101 turpin\u0101s gripas izplat\u012bba \u2013 aizvad\u012btaj\u0101 ned\u0113\u013c\u0101 saslimst\u012bba palielin\u0101j\u0101s l\u012bdz 18 procentiem laboratorisku apstiprin\u0101tu gripas paraugu, kam\u0113r iepriek\u0161\u0113j\u0101 ned\u0113\u013c\u0101 \u012bpatsvars bija 10,5 procenti. Taj\u0101 pa\u0161\u0101 laik\u0101 saslimst\u012bba joproj\u0101m ir zem\u0101ka nek\u0101 pirms sv\u0113tkiem, kad tika re\u0123istr\u0113ts sezonas augst\u0101kais r\u0101d\u012bt\u0101js.<\/p>\n
J\u0113kabpils novad\u0101 aizvad\u012btaj\u0101 ned\u0113\u013c\u0101 gripas intensit\u0101te bija otr\u0101 augst\u0101k\u0101 valst\u012b \u2013 626,5 gad\u012bjumi uz 100 t\u016bksto\u0161iem iedz\u012bvot\u0101ju. Savuk\u0101rt visaugst\u0101k\u0101 intensit\u0101te re\u0123istr\u0113ta Jelgav\u0101 \u2013 879,8 gad\u012bjumi uz 100 t\u016bksto\u0161iem iedz\u012bvot\u0101ju. Valst\u012b gripas gad\u012bjumu skaits vid\u0113ji ir 303,9 uz 100 t\u016bksto\u0161iem iedz\u012bvot\u0101ju.<\/p>\n
Vienlaikus saglab\u0101jas augsts ar\u012b citu ak\u016btu elpce\u013cu infekciju gad\u012bjumu skaits. Ar citu ak\u016btu elpce\u013cu infekciju simptomiem ned\u0113\u013cas laik\u0101 kop\u0101 v\u0113rsu\u0161ies 933 pacienti, kas veidoja 1343,7 gad\u012bjumus uz 100 000 iedz\u012bvot\u0101jiem, kas ir aptuveni iepriek\u0161\u0113j\u0101s ned\u0113\u013cas l\u012bmen\u012b, kad \u0161is l\u012bmenis bija 1389,6 gad\u012bjumi uz 100 000 iedz\u012bvot\u0101ju.<\/p>\n
Ambulatoraj\u0101s \u0101rstniec\u012bbas iest\u0101d\u0113s v\u0113r\u0161an\u0101s citu elpce\u013cu infekciju d\u0113\u013c aizvad\u012btaj\u0101 ned\u0113\u013c\u0101 bija aptuveni iepriek\u0161\u0113j\u0101s ned\u0113\u013cas l\u012bmen\u012b, savuk\u0101rt pneimoniju gad\u012bjumu skaits samazin\u0101j\u0101s par 18,9%.<\/p>\n
Stacion\u0101raj\u0101s \u0101rstniec\u012bbas iest\u0101d\u0113s smagu ak\u016btu respiratoru infekciju pacientu \u012bpatsvars no kop\u0113j\u0101 uz\u0146emto pacientu skaita saglab\u0101j\u0101s stabils un veidoja 3,5%, nor\u0101da SPKC.<\/p>\n
Liel\u0101ko da\u013cu no stacion\u0113tajiem smagu ak\u016btu respiratoru infekciju pacientiem veido personas vecum\u0101 virs 65 gadiem, kas apliecina paaugstin\u0101tu smagas slim\u012bbas gaitas risku senioru vid\u016b.<\/p>\n
Laboratoriskie izmekl\u0113jumi liecina, ka pag\u0101ju\u0161aj\u0101 ned\u0113\u013c\u0101 gripas v\u012bruss apstiprin\u0101ts 18% izmekl\u0113to paraugu. Visi laboratoriski apstiprin\u0101tie gripas v\u012brusi bija A tipa, domin\u0113jot A\/H3 gripas v\u012brusa apak\u0161tipam.<\/p>\n
Stacion\u0101raj\u0101s vesel\u012bbas apr\u016bpes iest\u0101d\u0113s gripas p\u0101rbaudei test\u0113ti 519 pacienti, tostarp 67 – 12,9%- gad\u012bjumu apstiprin\u0101ta gripa. A tipa gripa apstiprin\u0101ta 65 gad\u012bjumos un divos gad\u012bjumos apstiprin\u0101ta B tipa gripa.<\/p>\n
Aizvad\u012btaj\u0101 ned\u0113\u013c\u0101 nav sa\u0146emti pazi\u0146ojumi par n\u0101ves gad\u012bjumiem pacientiem ar apstiprin\u0101tu gripas infekciju.<\/p>\n
R\u012bgas Austrumu kl\u012bnisk\u0101s universit\u0101tes slimn\u012bcas Nacion\u0101laj\u0101 mikrobiolo\u0123ijas references laboratorij\u0101 aizvad\u012btaj\u0101 ned\u0113\u013c\u0101 uz gripas v\u012brusiem izmekl\u0113ti 438 kl\u012bniskie paraugi, no tiem 79 jeb 18% gad\u012bjumu apstiprin\u0101ta gripa. Noteikti A tipa gripas v\u012brusi: 11 A\/H3, septi\u0146i A\/H1pdm un 61 netip\u0113ts. Sal\u012bdzino\u0161i iepriek\u0161\u0113j\u0101 ned\u0113\u013c\u0101 \u0161is r\u0101d\u012bt\u0101js bija 41 jeb 10,5%.<\/p>\n
Savuk\u0101rt Covid-19 situ\u0101cija Latvij\u0101 aizvad\u012btaj\u0101 ned\u0113\u013c\u0101 liecina par nelielu pozit\u012bvo testu \u012bpatsvara samazin\u0101jumu l\u012bdz 6,5%, sal\u012bdzinot ar iepriek\u0161\u0113jo ned\u0113\u013cu. Veikti 554 testi, no tiem 36 – 6,5% – bija v\u012brusu apstiprino\u0161i.<\/p>\n
Slimn\u012bc\u0101s uz\u0146emti 39 Covid-19 infekcijas pacienti, kam\u0113r ned\u0113\u013cu iepriek\u0161 – 47. Kop\u0101 aizvad\u012btaj\u0101 ned\u0113\u013c\u0101 stacion\u0101ros \u0101rst\u0113ju\u0161ies 73 pacienti ar apstiprin\u0101tu Covid-19 infekciju, tai skait\u0101 ar pamata diagnozi Covid-19 bija 30 – 41,6% pacientu.<\/p>\n
Covid-19 infekcijas pozit\u012bvo testu \u012bpatsvars stacion\u0101ros palielin\u0101jies. Test\u0113ti 476 pacienti, no tiem 22 jeb 4,6% pacientu apstiprin\u0101ta Covid-19 infekcija. Sal\u012bdzin\u0101jumam ned\u0113\u013cu iepriek\u0161 t\u0101 tika apstiprin\u0101ta desmit jeb 2,1% pacientu.<\/p>\n
Vienlaikus slimn\u012bc\u0101s uz\u0146emto Covid-19 pacientu skaits samazin\u0101j\u0101s, tom\u0113r aizvad\u012btaj\u0101 ned\u0113\u013c\u0101 re\u0123istr\u0113ti \u010detri n\u0101ves gad\u012bjumi pacientiem ar apstiprin\u0101tu Covid-19 infekciju. Kop\u0161 gada s\u0101kuma kop\u0101 re\u0123istr\u0113ti 12 n\u0101ves gad\u012bjumi, savuk\u0101rt 2025. gad\u0101 kop\u0101 re\u0123istr\u0113ti 132 n\u0101ves gad\u012bjumi pacientiem ar Covid-19, liecina SPKC dati.<\/p>\n
Notek\u016bde\u0146u monitoringa dati r\u0101da, ka v\u012brusa koncentr\u0101cija Latvij\u0101 kopum\u0101 samazin\u0101s.<\/p>\n
\u0145emot v\u0113r\u0101 vienlaic\u012bgu gripas, citu elpce\u013cu infekciju un Covid-19 cirkul\u0101ciju, SPKC aicina iedz\u012bvot\u0101jus iev\u0113rot profilakses pas\u0101kumus – regul\u0101ri mazg\u0101t rokas, v\u0113din\u0101t telpas, izvair\u012bties no cilv\u0113ku pulc\u0113\u0161an\u0101s viet\u0101m un nepiecie\u0161am\u012bbas gad\u012bjum\u0101 lietot medic\u012bnisk\u0101s sejas maskas vai respiratorus. Saslim\u0161anas gad\u012bjum\u0101 ieteicams palikt m\u0101j\u0101s, sazin\u0101ties ar \u0123imenes \u0101rstu un iev\u0113rot \u0101rsta nor\u0101d\u012bjumus, lai mazin\u0101tu infekciju izplat\u012bbu.<\/p>\n
SPKC v\u0113r\u0161 uzman\u012bbu, ka vakcin\u0101cija pret gripu joproj\u0101m ir visefekt\u012bv\u0101kais veids, k\u0101 pasarg\u0101t sevi no smagas slim\u012bbas gaitas un komplik\u0101cij\u0101m. \u0145emot v\u0113r\u0101, ka gripa parasti turpina izplat\u012bties l\u012bdz pavasarim, vakcin\u0113ties ir lietder\u012bgi ar\u012b epid\u0113mijas laik\u0101.<\/p>\n
Iedz\u012bvot\u0101ji aicin\u0101ti sazin\u0101ties ar savu \u0123imenes \u0101rstu un noskaidrot, vai vakc\u012bnas joproj\u0101m ir pieejamas vi\u0146u \u0101rsta praks\u0113.<\/p>\n","protected":false},"excerpt":{"rendered":"Latvij\u0101 turpin\u0101s gripas izplat\u012bba \u2013 aizvad\u012btaj\u0101 ned\u0113\u013c\u0101 saslimst\u012bba palielin\u0101j\u0101s l\u012bdz 18 procentiem laboratorisku apstiprin\u0101tu gripas paraugu, kam\u0113r iepriek\u0161\u0113j\u0101…\n","protected":false},"author":2,"featured_media":111280,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[23,28,29,32,33,22,987,986,30,31,35,39,38,36,37,34,40,20,26,27,24,25,21],"class_list":{"0":"post-111279","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-aktualitates","8":"tag-aktualitates","9":"tag-breaking-news","10":"tag-breakingnews","11":"tag-featured-news","12":"tag-featurednews","13":"tag-headlines","14":"tag-jekabpils-zinas","15":"tag-jekabpilslaiks","16":"tag-latest-news","17":"tag-latestnews","18":"tag-latvia","19":"tag-latvian","20":"tag-latviesu","21":"tag-latviesu-valoda","22":"tag-latviesuvaloda","23":"tag-latvija","24":"tag-lv","25":"tag-news","26":"tag-popularakas-zinas","27":"tag-popularakaszinas","28":"tag-top-stories","29":"tag-topstories","30":"tag-zinas"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@lv\/115941401080050581","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/posts\/111279","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/comments?post=111279"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/posts\/111279\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/media\/111280"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/media?parent=111279"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/categories?post=111279"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/tags?post=111279"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}